Three seconds. That's how long it took. Your shoes. Your posture. The way you held your drink. Whether you looked at the floor or looked at her.
She already filed you away. Interesting. Boring. Safe. Bold. Before you even opened your mouth.
Everything you say after that is just her confirming what she already decided.
So stop rehearsing lines. Fix the first three seconds. Stand tall. Look up. Smile like you mean it. Walk like you belong wherever you're standing.
The words come later. The impression comes first.
www.medscape.com
Next Monday you'll feel more confident. After the gym you'll feel more confident. After one more drink you'll feel more confident. After you get a better haircut, a better jacket, a better job.
You've been "getting ready" for two years.
She's standing ten feet away right now. She'll be gone in four minutes. No amount of preparation will manufacture the courage that only comes from moving your feet.
Walk over. Stumble through the first sentence. Let it be clumsy. Let it be imperfect. You will feel more alive in those ten seconds than you have all month.
Holy crap.
How clever of them LOLEli Lilly Offers Obesity Drug Directly to Consumers
Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.
Didn’t realize it had beneficial effects to those with cardiovascular diseases.
Attraction runs on a clock.
She flirted for weeks. Touched your arm. Found reasons to be alone with you. And you were careful. Respectful. Waiting for the right moment.
The moment had a shelf life. It expired around month two, and by the time you asked her out, she'd quietly filed you under "little brother."
One of the hardest lessons inside the 22 Rules: women rarely wait. Interest either grows or it decays, and nothing decays it faster than a man who never moves.
Make the move while she's still inventing reasons to be near you.
This is a maneuver by drug companies after observing the market over the last year and a half. Whether you like it or not it is a bit ingenious. So there has been a shortage of Ozempic and Wagovy which diabetics were depending on. This was created because Dr's began prescribing them for the off label use for weight loss. Insurance companies caught on and began refusing to cover the drugs unless the patients were diabetic. So the drug companies took the same GLP1 agonist (Semiglutide) and combined it with things like B12 and or other drugs and supplements to create a new drug specifically for weight loss and that wouldn't interfere with the diabetics need for Ozempic etc. The drug wouldn't get prescribed to diabetics and is more likely to pass insurance company scrutiny because it's not an off label use. I imagine this report on heart health is another way to twist insurance company arms to paying for it. I bet the report was funded by the drug company, to prod doctors and insurance companies to cover it as they do statins. I'm not saying the heart health report is a lie, in fact it makes sense that if a person is obese and loses weight, that their heart health would improve.Eli Lilly Offers Obesity Drug Directly to Consumers
Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.
Didn’t realize it had beneficial effects to those with cardiovascular diseases.
Not sure what makes you think that or how I said I was for or against this specific drugs availability. Care to explain?